Status:

ACTIVE_NOT_RECRUITING

SoftHand Comparison Study

Lead Sponsor:

Mayo Clinic

Collaborating Sponsors:

Arizona State University

Hanger Clinic: Prosthetics & Orthotics

Conditions:

Upper Extremity Injury

Upper Extremity Deformities, Congenital

Eligibility:

All Genders

18-99 years

Phase:

NA

Brief Summary

A trial to compare the performance of the SoftHand Pro (SHP) and Ossur i-Limb in people with transradial limb loss over an 8-week period.

Detailed Description

This study will measure improvements in outcomes obtained from laboratory testing of the SHP and i-Limb from baseline to after 8 weeks of daily use. A secondary analysis will incorporate the subjects'...

Eligibility Criteria

Inclusion

  • the individual can successfully use their prosthesis, list the components used and that their current prosthesis is fitting properly (by performing a tension analysis);
  • the individual had unilateral transradial limb loss more than 6 months before the clinical evaluation because, to use a myoelectric prosthesis, the residual limb volume needs to be stable;
  • the individual is a proficient owner of one or more common myoelectric prosthetic hands, such as the Sensor Hand Speed and Bebionic.

Exclusion

  • individuals who have had transradial amputation for less than 6 months;
  • individuals who have been fit and trained to use a prosthesis but chose not to use one;
  • individuals who use the i-Limb Quantum myoelectric prosthesis;
  • symptomatic brachial plexopathy, cervical radiculopathy or polyneuropathy (observed);
  • orthopedic, joint degeneration (i.e., arthritis, self-reported) affecting the hand or cervical spine that severely limit upper limb function (observed);
  • visual problems that would interfere with the grasping;
  • co-existing central nervous system disease with symptoms that limit upper extremity function (e.g., multiple sclerosis, motor neuron disease, myasthenia gravis, Parkinson's disease, dystonia) revealed in medical history;
  • limited range of motion as assessed through range of motion testing;
  • inability to follow study instructions;
  • use of medications that might affect sensory and/or motor functions.

Key Trial Info

Start Date :

April 28 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2026

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT05328934

Start Date

April 28 2022

End Date

May 1 2026

Last Update

October 14 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Arizona State University

Tempe, Arizona, United States, 85281-9709

2

Mayo Clinic

Rochester, Minnesota, United States, 55905